Aegon (AGN) AGM 2026 summary

Opening remarks and agenda

• Meeting opened by the Chair, with introductions of board members and key executives present, including the CEO, CFO, and Company Secretary.

• Voting procedures and virtual participation explained, with live voting and Q&A enabled through the Lumi system.

• Confirmation that the meeting was convened in accordance with bylaws and legal requirements for Bermuda, Dutch, and U.S. listings.

Financial performance review

• Achieved or exceeded EUR 500 million in share buybacks and around EUR 600 million in dividends for 2025.

• Sale of Aegon UK to Standard Life for GBP 750 million plus shares valued at GBP 2 billion.

• Generated EUR 1.3 billion in operating capital and EUR 829 million in free cash flow, both ahead of targets.

• Dividend per share grew by double digits to EUR 0.40; group leverage maintained at EUR 5 billion.

• Operating result increased to EUR 1.7 billion, with business growth across all units.

Strategic initiatives and plans

• Announced relocation of head office and legal seat to the U.S., aiming for completion by January 2028.

• Strategic review and sale of Aegon UK completed; focus sharpened on becoming a leading U.S. life insurance and retirement group.

• U.S. GAAP implementation underway, with plans to report under this standard for the full year 2027.

• Gradual operational shift from Amsterdam to the U.S. planned, with employee engagement highlighted.

• Dual listings on Euronext and NYSE to be maintained, with future inclusion in U.S.-focused indices targeted.